Pharmaceutical-Biotech Global Build Report: Top 5 Projects Deliver $4 Billion Investment
Pharmaceutical-Biotech Global Build Report: Top 5 Projects Deliver $4 Billion Investment
SUGAR LAND--November 30, 2016--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--While the majority of people bemoan the cost of prescription drugs, few understand the cost of producing those drugs. And this is after having invested billions in developing a drug. The production process is closely monitored, highly regulated and requires a huge capital investment. This fact is illustrated by looking at just the top five manufacturing projects that have or will kick off this year, which reveals a total investment value (TIV) of $4.1 billion.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- COVID-19 Underscores Need for Drug Manufacturing to Return to U.S. Shores
- U.S. Mid-Atlantic Region Sees Strong Life Science Capital Construction Acti...
- Join Industrial Info for a Webinar on the Pharmaceutical-Biotech Industry
- Industrial Info's Disaster Impact Tracker Monitors Path of Hurricane Floren...
- Industrial Info to Present Webinar on Global Pharmaceutical-Biotech Project...